Chenghui Shuangda
Recently, the 91st China International Pharmaceutical API/Intermediates/Packaging/Equipment Fair (API China) was successfully concluded at Xi'an International Conference and Exhibition Center. The scale of this conference reached 69,000 square meters, with more than 3,100 booths and more than 1,000 domestic and foreign excellent enterprises, focusing on the exhibition of pharmaceutical APIs, intermediates, natural products, pharmaceutical excipients, pharmaceutical packaging, pharmaceutical equipment, outsourcing services, biopharmaceuticals and other dozens of major categories, more than 300 sub-categories of more than 100,000 products.
Highlights
Led by the company's executives, the marketing team warmly received every visiting partner and industry elite. Through in-depth face-to-face communication, we not only deepened the cooperative relationship with existing customers, but also successfully attracted the interest of more potential customers, and enhanced the brand awareness and trust of ChengHui. The exhibition also strengthened mutual trust and cooperation with core customers, laying a solid foundation for future in-depth strategic cooperation between the two sides.
We sincerely thank each and every one of our customers and friends who came to the show for your support and trust! Although the exhibition has come to an end, but the prologue of cooperation has just been opened, we look forward to working with new and old customers hand in hand, the introduction of more cost-effective high-quality products, to provide one-stop service program, and jointly promote the progress of the pharmaceutical industry, for the cause of human health to contribute to a greater strength!
About us
Shandong Chenghui Pharmaceutical Group Co., Ltd. was founded in June 2002, with a registered capital of 130 million yuan, headquartered in Jinan, Shandong Province. It is a high-tech enterprise focusing on the research and development, production, sales and service of pharmaceutical APIs, intermediates and fine chemicals, and is committed to the research and development and application of new technologies in the fields of MAH, CDMO, veterinary medicine and agrochemicals, etc. The Group now has one R&D center - Shandong Chengchuang Blue Ocean Pharmaceutical Technology Co.
The group now has one R&D center-Shandong Chengchuang Blue Ocean Pharmaceutical Technology Co., Ltd, one API plant-Shandong Chenghui Shuangda Pharmaceutical Co., Ltd and two pharmaceutical intermediates production bases, with more than 1,000 employees, and more than 300 R&D team members.
